BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.
BiomX: BX004 Phage Cocktail Pt 2, Phase 1b/2a Clinical Results In Cystic Fibrosis Expected seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
BiomX Inc. (NYSEAMERICAN:PHGE – Free Report) – Equities research analysts at HC Wainwright cut their FY2023 earnings per share estimates for shares of BiomX in a report released on Tuesday, November 14th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings per share of ($0.56) for the year, down from their […]
BiomX Reports Third Quarter 2023 Financial Results and Provides Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.